(HealthDay)—Exjade (deferasirox) has been approved by the U.S. Food and Drug Administration to remove excess iron in the blood among people with a genetic blood disorder called non-transfusion-dependent thalassemia (NTDT).
Jan 24, 2013
0
0
Some six million patients in Iran are affected by Western economic sanctions as import of medicine is becoming increasingly difficult, a governmental paper reported Sunday quoting a health official.
Oct 21, 2012
1
0
In order for the body to function, a balance is necessary between the cells that build up the bones in our skeletons and the cells that break them down. In the disease malignant infantile osteopetrosis, MIOP, the cells that ...
Sep 5, 2012
0
0
